Cribstone Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.45K | Hold |
38
| – | – | ﹤0.01% | 312 |
|
|
2022
Q3 | $3K | Hold |
38
| – | – | ﹤0.01% | 327 |
|
|
2022
Q2 | $3K | Buy |
38
+12
| +46% | +$947 | ﹤0.01% | 330 |
|
|
2022
Q1 | $2K | Buy |
26
+1
| +4% | +$77 | ﹤0.01% | 355 |
|
|
2021
Q4 | $2K | Hold |
25
| – | – | ﹤0.01% | 350 |
|
|
2021
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 339 |
|
|
2021
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 318 |
|
|
2021
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 308 |
|
|
2020
Q4 | $2K | Hold |
25
| – | – | ﹤0.01% | 297 |
|
|
2020
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 261 |
|
|
2020
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 295 |
|
|
2020
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 299 |
|
|
2019
Q4 | $2K | Sell |
25
-323
| -93% | -$25.8K | ﹤0.01% | 347 |
|
|
2019
Q3 | $30K | Sell |
348
-200
| -36% | -$17.2K | 0.02% | 282 |
|
|
2019
Q2 | $50K | Sell |
548
-180
| -25% | -$16.4K | 0.03% | 243 |
|
|
2019
Q1 | $63K | Sell |
728
-468
| -39% | -$40.5K | 0.03% | 207 |
|
|
2018
Q4 | $92K | Hold |
1,196
| – | – | 0.05% | 181 |
|
|
2018
Q3 | $92K | Hold |
1,196
| – | – | 0.04% | 200 |
|
|
2018
Q2 | $81K | Sell |
1,196
-341
| -22% | -$23.1K | 0.04% | 212 |
|
|
2018
Q1 | $111K | Buy |
1,537
+223
| +17% | +$16.1K | 0.05% | 176 |
|
|
2017
Q4 | $99K | Buy |
1,314
+281
| +27% | +$21.2K | 0.05% | 203 |
|
|
2017
Q3 | $79K | Sell |
1,033
-197
| -16% | -$15.1K | 0.04% | 203 |
|
|
2017
Q2 | $92K | Sell |
1,230
-220
| -15% | -$16.5K | 0.05% | 195 |
|
|
2017
Q1 | $96K | Buy |
1,450
+633
| +77% | +$41.9K | 0.05% | 201 |
|
|
2016
Q4 | $52K | Hold |
817
| – | – | 0.03% | 257 |
|
|
2016
Q3 | $56K | Hold |
817
| – | – | 0.03% | 248 |
|
|
2016
Q2 | $60K | Buy |
+817
| New | +$60K | 0.04% | 246 |
|